Liquid Biopsy Diagnostic Tool Market, Global Outlook and Forecast 2023-2029
Report Code: KNJ1461040 No. of Pages: 104 Category: Medical Devices
Publisher: Date of Publish:
Publisher: Date of Publish:
This report aims to provide a comprehensive presentation of the global market for Liquid Biopsy Diagnostic Tool, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liquid Biopsy Diagnostic Tool. This report contains market size and forecasts of Liquid Biopsy Diagnostic Tool in global, including the following market information:
Global Liquid Biopsy Diagnostic Tool Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Liquid Biopsy Diagnostic Tool market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Instrument Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Liquid Biopsy Diagnostic Tool include Biocept, Qiagen, Roche Diagnostics, Bio-Rad Laboratories, Myriad Genetics, Menarini-Silicon Biosystems, Trovagene, Guardant Health and Mdxhealth, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Liquid Biopsy Diagnostic Tool companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liquid Biopsy Diagnostic Tool Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Liquid Biopsy Diagnostic Tool Market Segment Percentages, by Type, 2022 (%)
Instrument
Reagent
Other
Global Liquid Biopsy Diagnostic Tool Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Liquid Biopsy Diagnostic Tool Market Segment Percentages, by Application, 2022 (%)
Hospital
Third-party Testing Agency
Global Liquid Biopsy Diagnostic Tool Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Liquid Biopsy Diagnostic Tool Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Liquid Biopsy Diagnostic Tool revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Liquid Biopsy Diagnostic Tool revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biocept
Qiagen
Roche Diagnostics
Bio-Rad Laboratories
Myriad Genetics
Menarini-Silicon Biosystems
Trovagene
Guardant Health
Mdxhealth
Genomic Health
Raindance Technologies
Thermo Fisher Scientific
Illumina
Amoy Diagnostics
Johnson & Johnson
Outline of Major Chapters:
Chapter 1: Introduces the definition of Liquid Biopsy Diagnostic Tool, market overview.
Chapter 2: Global Liquid Biopsy Diagnostic Tool market size in revenue.
Chapter 3: Detailed analysis of Liquid Biopsy Diagnostic Tool company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Liquid Biopsy Diagnostic Tool in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Liquid Biopsy Diagnostic Tool Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Liquid Biopsy Diagnostic Tool Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Liquid Biopsy Diagnostic Tool Overall Market Size
2.1 Global Liquid Biopsy Diagnostic Tool Market Size: 2022 VS 2029
2.2 Global Liquid Biopsy Diagnostic Tool Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Liquid Biopsy Diagnostic Tool Players in Global Market
3.2 Top Global Liquid Biopsy Diagnostic Tool Companies Ranked by Revenue
3.3 Global Liquid Biopsy Diagnostic Tool Revenue by Companies
3.4 Top 3 and Top 5 Liquid Biopsy Diagnostic Tool Companies in Global Market, by Revenue in 2022
3.5 Global Companies Liquid Biopsy Diagnostic Tool Product Type
3.6 Tier 1, Tier 2 and Tier 3 Liquid Biopsy Diagnostic Tool Players in Global Market
3.6.1 List of Global Tier 1 Liquid Biopsy Diagnostic Tool Companies
3.6.2 List of Global Tier 2 and Tier 3 Liquid Biopsy Diagnostic Tool Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Liquid Biopsy Diagnostic Tool Market Size Markets, 2022 & 2029
4.1.2 Instrument
4.1.3 Reagent
4.1.4 Other
4.2 By Type - Global Liquid Biopsy Diagnostic Tool Revenue & Forecasts
4.2.1 By Type - Global Liquid Biopsy Diagnostic Tool Revenue, 2018-2023
4.2.2 By Type - Global Liquid Biopsy Diagnostic Tool Revenue, 2024-2029
4.2.3 By Type - Global Liquid Biopsy Diagnostic Tool Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Liquid Biopsy Diagnostic Tool Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Third-party Testing Agency
5.2 By Application - Global Liquid Biopsy Diagnostic Tool Revenue & Forecasts
5.2.1 By Application - Global Liquid Biopsy Diagnostic Tool Revenue, 2018-2023
5.2.2 By Application - Global Liquid Biopsy Diagnostic Tool Revenue, 2024-2029
5.2.3 By Application - Global Liquid Biopsy Diagnostic Tool Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Liquid Biopsy Diagnostic Tool Market Size, 2022 & 2029
6.2 By Region - Global Liquid Biopsy Diagnostic Tool Revenue & Forecasts
6.2.1 By Region - Global Liquid Biopsy Diagnostic Tool Revenue, 2018-2023
6.2.2 By Region - Global Liquid Biopsy Diagnostic Tool Revenue, 2024-2029
6.2.3 By Region - Global Liquid Biopsy Diagnostic Tool Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Liquid Biopsy Diagnostic Tool Revenue, 2018-2029
6.3.2 US Liquid Biopsy Diagnostic Tool Market Size, 2018-2029
6.3.3 Canada Liquid Biopsy Diagnostic Tool Market Size, 2018-2029
6.3.4 Mexico Liquid Biopsy Diagnostic Tool Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Liquid Biopsy Diagnostic Tool Revenue, 2018-2029
6.4.2 Germany Liquid Biopsy Diagnostic Tool Market Size, 2018-2029
6.4.3 France Liquid Biopsy Diagnostic Tool Market Size, 2018-2029
6.4.4 U.K. Liquid Biopsy Diagnostic Tool Market Size, 2018-2029
6.4.5 Italy Liquid Biopsy Diagnostic Tool Market Size, 2018-2029
6.4.6 Russia Liquid Biopsy Diagnostic Tool Market Size, 2018-2029
6.4.7 Nordic Countries Liquid Biopsy Diagnostic Tool Market Size, 2018-2029
6.4.8 Benelux Liquid Biopsy Diagnostic Tool Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Liquid Biopsy Diagnostic Tool Revenue, 2018-2029
6.5.2 China Liquid Biopsy Diagnostic Tool Market Size, 2018-2029
6.5.3 Japan Liquid Biopsy Diagnostic Tool Market Size, 2018-2029
6.5.4 South Korea Liquid Biopsy Diagnostic Tool Market Size, 2018-2029
6.5.5 Southeast Asia Liquid Biopsy Diagnostic Tool Market Size, 2018-2029
6.5.6 India Liquid Biopsy Diagnostic Tool Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Liquid Biopsy Diagnostic Tool Revenue, 2018-2029
6.6.2 Brazil Liquid Biopsy Diagnostic Tool Market Size, 2018-2029
6.6.3 Argentina Liquid Biopsy Diagnostic Tool Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Liquid Biopsy Diagnostic Tool Revenue, 2018-2029
6.7.2 Turkey Liquid Biopsy Diagnostic Tool Market Size, 2018-2029
6.7.3 Israel Liquid Biopsy Diagnostic Tool Market Size, 2018-2029
6.7.4 Saudi Arabia Liquid Biopsy Diagnostic Tool Market Size, 2018-2029
6.7.5 UAE Liquid Biopsy Diagnostic Tool Market Size, 2018-2029
7 Liquid Biopsy Diagnostic Tool Companies Profiles
7.1 Biocept
7.1.1 Biocept Company Summary
7.1.2 Biocept Business Overview
7.1.3 Biocept Liquid Biopsy Diagnostic Tool Major Product Offerings
7.1.4 Biocept Liquid Biopsy Diagnostic Tool Revenue in Global Market (2018-2023)
7.1.5 Biocept Key News & Latest Developments
7.2 Qiagen
7.2.1 Qiagen Company Summary
7.2.2 Qiagen Business Overview
7.2.3 Qiagen Liquid Biopsy Diagnostic Tool Major Product Offerings
7.2.4 Qiagen Liquid Biopsy Diagnostic Tool Revenue in Global Market (2018-2023)
7.2.5 Qiagen Key News & Latest Developments
7.3 Roche Diagnostics
7.3.1 Roche Diagnostics Company Summary
7.3.2 Roche Diagnostics Business Overview
7.3.3 Roche Diagnostics Liquid Biopsy Diagnostic Tool Major Product Offerings
7.3.4 Roche Diagnostics Liquid Biopsy Diagnostic Tool Revenue in Global Market (2018-2023)
7.3.5 Roche Diagnostics Key News & Latest Developments
7.4 Bio-Rad Laboratories
7.4.1 Bio-Rad Laboratories Company Summary
7.4.2 Bio-Rad Laboratories Business Overview
7.4.3 Bio-Rad Laboratories Liquid Biopsy Diagnostic Tool Major Product Offerings
7.4.4 Bio-Rad Laboratories Liquid Biopsy Diagnostic Tool Revenue in Global Market (2018-2023)
7.4.5 Bio-Rad Laboratories Key News & Latest Developments
7.5 Myriad Genetics
7.5.1 Myriad Genetics Company Summary
7.5.2 Myriad Genetics Business Overview
7.5.3 Myriad Genetics Liquid Biopsy Diagnostic Tool Major Product Offerings
7.5.4 Myriad Genetics Liquid Biopsy Diagnostic Tool Revenue in Global Market (2018-2023)
7.5.5 Myriad Genetics Key News & Latest Developments
7.6 Menarini-Silicon Biosystems
7.6.1 Menarini-Silicon Biosystems Company Summary
7.6.2 Menarini-Silicon Biosystems Business Overview
7.6.3 Menarini-Silicon Biosystems Liquid Biopsy Diagnostic Tool Major Product Offerings
7.6.4 Menarini-Silicon Biosystems Liquid Biopsy Diagnostic Tool Revenue in Global Market (2018-2023)
7.6.5 Menarini-Silicon Biosystems Key News & Latest Developments
7.7 Trovagene
7.7.1 Trovagene Company Summary
7.7.2 Trovagene Business Overview
7.7.3 Trovagene Liquid Biopsy Diagnostic Tool Major Product Offerings
7.7.4 Trovagene Liquid Biopsy Diagnostic Tool Revenue in Global Market (2018-2023)
7.7.5 Trovagene Key News & Latest Developments
7.8 Guardant Health
7.8.1 Guardant Health Company Summary
7.8.2 Guardant Health Business Overview
7.8.3 Guardant Health Liquid Biopsy Diagnostic Tool Major Product Offerings
7.8.4 Guardant Health Liquid Biopsy Diagnostic Tool Revenue in Global Market (2018-2023)
7.8.5 Guardant Health Key News & Latest Developments
7.9 Mdxhealth
7.9.1 Mdxhealth Company Summary
7.9.2 Mdxhealth Business Overview
7.9.3 Mdxhealth Liquid Biopsy Diagnostic Tool Major Product Offerings
7.9.4 Mdxhealth Liquid Biopsy Diagnostic Tool Revenue in Global Market (2018-2023)
7.9.5 Mdxhealth Key News & Latest Developments
7.10 Genomic Health
7.10.1 Genomic Health Company Summary
7.10.2 Genomic Health Business Overview
7.10.3 Genomic Health Liquid Biopsy Diagnostic Tool Major Product Offerings
7.10.4 Genomic Health Liquid Biopsy Diagnostic Tool Revenue in Global Market (2018-2023)
7.10.5 Genomic Health Key News & Latest Developments
7.11 Raindance Technologies
7.11.1 Raindance Technologies Company Summary
7.11.2 Raindance Technologies Business Overview
7.11.3 Raindance Technologies Liquid Biopsy Diagnostic Tool Major Product Offerings
7.11.4 Raindance Technologies Liquid Biopsy Diagnostic Tool Revenue in Global Market (2018-2023)
7.11.5 Raindance Technologies Key News & Latest Developments
7.12 Thermo Fisher Scientific
7.12.1 Thermo Fisher Scientific Company Summary
7.12.2 Thermo Fisher Scientific Business Overview
7.12.3 Thermo Fisher Scientific Liquid Biopsy Diagnostic Tool Major Product Offerings
7.12.4 Thermo Fisher Scientific Liquid Biopsy Diagnostic Tool Revenue in Global Market (2018-2023)
7.12.5 Thermo Fisher Scientific Key News & Latest Developments
7.13 Illumina
7.13.1 Illumina Company Summary
7.13.2 Illumina Business Overview
7.13.3 Illumina Liquid Biopsy Diagnostic Tool Major Product Offerings
7.13.4 Illumina Liquid Biopsy Diagnostic Tool Revenue in Global Market (2018-2023)
7.13.5 Illumina Key News & Latest Developments
7.14 Amoy Diagnostics
7.14.1 Amoy Diagnostics Company Summary
7.14.2 Amoy Diagnostics Business Overview
7.14.3 Amoy Diagnostics Liquid Biopsy Diagnostic Tool Major Product Offerings
7.14.4 Amoy Diagnostics Liquid Biopsy Diagnostic Tool Revenue in Global Market (2018-2023)
7.14.5 Amoy Diagnostics Key News & Latest Developments
7.15 Johnson & Johnson
7.15.1 Johnson & Johnson Company Summary
7.15.2 Johnson & Johnson Business Overview
7.15.3 Johnson & Johnson Liquid Biopsy Diagnostic Tool Major Product Offerings
7.15.4 Johnson & Johnson Liquid Biopsy Diagnostic Tool Revenue in Global Market (2018-2023)
7.15.5 Johnson & Johnson Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com